GIANNOTTA, JURI ALESSANDRO
GIANNOTTA, JURI ALESSANDRO
Universita' degli Studi di MILANO
Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature
2026 S. Rao, A. Liparoti, J.A. Giannotta, A. Artoni, A. Muscatello, A. Bandera, F. Peyvandi
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
2025 P. Agosti, I. Mancini, A. Artoni, C. Cardone, P. De Leo, C. Bichard, A. Truma, B. Ferrari, J.A. Giannotta, N.N. Fantini, M.C. Mocellin, D. Prati, F. Peyvandi
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study
2025 J.A. Giannotta, A. Artoni, I. Mancini, P. Agosti, M. Carpenedo, A. Truma, S. Miri, B. Ferrari, P. De Leo, P. Salutari, G. Mancini, A. Molteni, E. Rinaldi, M. Bocchia, M. Napolitano, L. Prezioso, A. Cuccaro, E. Scarpa, A. Condorelli, D. Grimaldi, M. Massaia, F. Peyvandi
Automation in Platelet Function Testing: Current Challenges and Future Directions
2025 F. Boggio, J.A. Giannotta, A. Lecchi
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Treatment of immune-mediated thrombotic thrombocytopenic purpura without plasma exchange
2024 M. Capecchi, G. Gazzola, P. Agosti, P. De Leo, I. Mancini, B. Ferrari, J.A. Giannotta, A. Artoni, F. Peyvandi
Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP‐NET survey
2024 B. Fattizzo, V. Carrai, M. Crugnola, E. Baldacci, M. Bellini, C. Bosi, E. Buzzatti, D. Caramazza, G. Carli, M. Carpenedo, C. Clissa, C. Danesin, M.R. De Paolis, J.A. Giannotta, V. Innao, M. Marchetti, U. Markovic, A. Morotti, M. Napolitano, A. Patriarca, L. Pettine, A. Poloni, E. Rivolti, E. Rossi, T.M. Santeremo, C. Santoro, M.E. Zannier, F. Zaja, S. Cantoni, F. Palandri, V. De Stefano
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
2024 A. Truma, A. Artoni, J.A. Giannotta, M. Caronni, F. Peyvandi
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura
2024 A. Truma, I. Mancini, P. Agosti, A. Artoni, J.A. Giannotta, B. Ferrari, P. De Leo, F. Peyvandi
Intravenous immunoglobulins in autoimmune cytopenias: an old tool with an alternative dosing schedule
2023 J.A. Giannotta, M. Capecchi, B. Fattizzo, A. Artoni, W. Barcellini
SARS‐CoV‐2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey
2022 J.A. Giannotta, B. Fattizzo, M. Bortolotti, C. Girmenia, C. Ielo, E. Metafuni, A. Visentin, V. Apolito, A. Lucchesi, V. Giai, E. Beggiato, E. Di Bona, F. Giglio, S. Sica, A.P. Iori, W. Barcellini
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers
2022 B. Fattizzo, S. Cantoni, J.A. Giannotta, L. Bandiera, R. Zavaglia, M. Bortolotti, W. Barcellini
Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures
2022 B. Fattizzo, M. Bortolotti, J.A. Giannotta, D. Consonni, S. Cantoni, W. Barcellini
Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
2022 B. Fattizzo, M. Bortolotti, J.A. Giannotta, A. Zaninoni, D. Consonni, W. Barcellini
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series
2022 S. Pelusi, L. Ronzoni, F. Malvestiti, C. Bianco, I. Marini, R. D'Ambrosio, J.A. Giannotta, G. Soardo, M. Maggioni, D. Prati, L. Valenti
Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years
2022 C. Vercellati, A. Zaninoni, A.P. Marcello, E. Fermo, B. Fattizzo, J.A. Giannotta, P. Bianchi, A. Zanella, W. Barcellini
Breakthrough haemolysis in paroxysmal nocturnal haemoglobinuria after COVID-19 infection and COVID vaccination: what is worse?
2022 F. Cavallaro, M.C. Pasquini, J.A. Giannotta, F. Cattina, W. Barcellini, B. Fattizzo
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
2022 B. Fattizzo, G.V. Levati, J.A. Giannotta, G. Cassanello, L.M. Cro, A. Zaninoni, M. Barbieri, G.A. Croci, N. Revelli, W. Barcellini
Bortezomib in autoimmune hemolytic anemia and beyond
2021 R. Pasquale, J.A. Giannotta, W. Barcellini, B. Fattizzo
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study
2021 B. Fattizzo, M. Michel, A. Zaninoni, J. Giannotta, S. Guillet, H. Frederiksen, J. Vos, F. Mauro, B. Jilma, A. Patriarca, F. Zaja, A. Hill, S. Berentsen, W. Barcellini